Ondrej Hrusak Selected Research

Biomarkers (Surrogate Marker)

1/2019

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ondrej Hrusak Research Topics

Disease

10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 04/2005
4	Residual Neoplasm 01/2021 - 01/2013
4	Leukemia 01/2018 - 06/2010
2	COVID-19 10/2023 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 06/2010
1	COVID-19 related pediatric multisystem inflammatory disease 10/2023
1	Fever (Fevers) 01/2022
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Enteritis 01/2022
1	Central Nervous System Vasculitis 01/2022
1	Infections 01/2022
1	Disease Progression 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Vascular Skin Diseases 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021
1	Obesity 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Brain Neoplasms (Brain Tumor) 05/2019
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2019
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 11/2018
1	Neoplasms (Cancer) 11/2018
1	Pancytopenia 03/2016
1	Polyneuropathies (Polyneuropathy) 03/2016
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 03/2016
1	Sepsis (Septicemia) 03/2016
1	Trisomy (Trisomies) 01/2016

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 01/2013
2	blinatumomabIBA 01/2022 - 01/2021
2	AntigensIBA 01/2018 - 04/2005
2	Proteins (Proteins, Gene)FDA Link 04/2016 - 08/2011
1	CytokinesIBA 10/2023
1	InterferonsIBA 10/2023
1	AutoantibodiesIBA 10/2023
1	ruxolitinibIBA 01/2022
1	Janus Kinase 1IBA 01/2022
1	Toll-Like Receptor 8IBA 01/2022
1	src-Family KinasesIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	SmokeIBA 01/2020
1	SuspensionsIBA 05/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2018
1	alanyl-leucyl-alanyl-leucine (ALAL)IBA 01/2018
1	Antigen Receptors (Antigen Receptor)IBA 01/2017
1	Vincristine (Oncovin)FDA LinkGeneric 03/2016
1	Protein Isoforms (Isoforms)IBA 03/2013
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Monoclonal AntibodiesIBA 08/2011
1	drebrinsIBA 08/2011
1	Immunoglobulins (Immunoglobulin)IBA 06/2010

Therapy/Procedure

5	Therapeutics 01/2022 - 06/2010
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
2	Consolidation Chemotherapy 01/2022 - 01/2021
1	Ligation 03/2013
1	Aftercare (After-Treatment) 01/2013